ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 2897

Hydroxychloroquine Blood Levels Show Significant Trend Test for Risk of Retinopathy

Michelle Petri1, Marwa Elkhalifa2, Daniel Goldman1, Laurence S Magder3 and Mandeep Singh4, 1Medicine (Rheumatology), Johns Hopkins University School of Medicine, Baltimore, MD, 2Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 3Epidemiology and Public health, University of Maryland School of Medicine, Baltimore, MD, 4Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Hydroxychloroquine, ocular involvement and systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Date: Tuesday, October 23, 2018

Session Title: 5T111 ACR Abstract: SLE–Clinical IV: Clinical Outcomes (2892–2897)

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Hydroxychloroquine (HCQ) retinopathy after 10 years or more of use is more frequent than previously appreciated. This led to new ophthalmology guidelines that changed the recommended dosing from 6.5 mg/kg to 5 mg/kg. However, it is not clear that the lower dose of hydroxychloroquine will have the same efficacy for SLE activity or the same protective role against cardiovascular risk factors and thrombosis. We asked whether hydroxychloroquine blood levels could help identify those at greater future risk of retinopathy.

Methods: We analyzed data on 477 SLE patients from a clinical cohort who had repeated assessments of HCQ blood concentrations, and were evaluated one or more times for retinopathy (306 single retinopathy exam, 115 two and 58 three or more assessments). The patients were 93% female and 42% Caucasian. Hydroxychloroquine blood levels were performed as previously described. In our analysis, HCQ toxicity was defined dichotomously by a retina expert: all those with a value of “No” or “Possible” were categorized as not having HCQ toxicity, and those who had a “Yes” were categorized as having it. Mean and maximum HCQ blood concentration over all cohort visits prior to the final retinopathy assessment were calculated. Risk of HCQ toxicity was then assessed in tertiles defined by these variables. The duration of hydroxychloroquine use (years in tertiles by distribution) and its association with HCQ toxicity were also examined.

Results: The risk of HCQ toxicity is shown in Table 1.

Table 1. Risk of HCQ retinal toxicity by variable.

No

Yes

Characteristic

n (%)

n (%)

p

P for Trend

Sex

0.0479

Female

423 (96.1)

17 (3.9)

Male

33 (89.2)

4 (10.8)

Ethnicity

0.3165

White

210 (94.2)

13 (5.8)

Black

193 (96.5)

7 (3.5)

Other

53 (98.2)

1 (1.8)

Age

0.0001

<0.0001

<45

189 (99.5)

1 (0.5)

45-59

157 (95.7)

7 (4.3)

60+

110 (89.4)

13 (10.6)

HCQ max

0.0923

0.045

1 (0 to 1194)

145 (98.6)

2 (1.4)

2 (1195 to 1732)

137 (94.5)

8 (5.5)

3 (1733 to 5873)

138 (93.9)

9 (6.1)

HCQ duration

0.0003

1 (0 to 8yrs)

145 (99.3)

1 (0.7)

2 (9 to 15yrs)

148 (97.4)

4 (2.6)

3 (16 to 52yrs)

139 (90.3)

15 (9.7)

BMI

<20

20-25

25-30

30-35

35+

–

43 (97.7)

151 (97.4)

144 (95.4))

66 (94.3)

50 (90.9)

–

1 (2.3)

4 (2.6)

7 (4.6)

4 (5.7)

5 (9.1)

0.3025

0.034

Patients had a variety of retinal testing done, with optical coherence testing most frequent. Table 2 shows the concordance of a test abnormality with the retina expert opinion.

Table 2 – Performance of retinal imaging modalities relative to expert diagnosis

Test

Retinopathy
N (%)

No Retinopathy
N (%)

Ocular Coherence Tomography (OCT)

Abnormal

23 (92%)

106 (15%)

Normal

2 (8%)

605 (85%)

Total

25

711

Electroretinogram (ERG)

Abnormal

14 (100%)

142 (40%)

Normal

0 (0%)

210 (60%)

Total

14

352

Microperimetry (MP1)

Abnormal

14 (100%)

98 (24%)

Normal

0 (0%)

307 (76%)

Total

14

405

Fundal Autoflourescence (FAF)

Abnormal

16 (76%)

144 (24%)

Normal

5 (24%)

462 (76%)

Total

21

606

OCT Sensitivity = 85%, Specificity = 92%

ERG Sensitivity = 100%; Specificity = 60%

MP1 Sensitivity = 100%; Specificity = 76%

FAF Sensitivity = 76%; Specificity = 76%

Conclusion: Our data show that the risk of HCQ retinopathy increases in men, Caucasians, older patients and with duration (but the frequency was less than in other publications). For the first time, out data show the utility of HCQ blood levels in predicting retinopathy. This would allow clinicians to either decrease dose or increase monitoring in those with high blood levels. Our data also show the need for ophthalmologists with retinopathy expertise to interpret retina testing, as screening tests can be abnormal due to causes other than HCQ retinopathy. Stopping HCQ based on an abnormal test without confirmation from a retinopathy expert could needlessly deprive an SLE patient of an important medication.


Disclosure: M. Petri, EMD Serono, 5,Exagen, 2,Janssen, 5,GSK, 5,AstraZeneca, 2,Inova Diagnostic, 5,Novartis, 5,Amgen Inc., 5,Decision Resources, 5,Medscape, 5,Eli Lilly and Co., 5,Quintiles, 5; M. Elkhalifa, None; D. Goldman, Merck & Co., Pfizer, 1; L. S. Magder, None; M. Singh, None.

To cite this abstract in AMA style:

Petri M, Elkhalifa M, Goldman D, Magder LS, Singh M. Hydroxychloroquine Blood Levels Show Significant Trend Test for Risk of Retinopathy [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 10). https://acrabstracts.org/abstract/hydroxychloroquine-blood-levels-show-significant-trend-test-for-risk-of-retinopathy/. Accessed February 27, 2021.
  • Tweet
  • Email
  • Print
Save to PDF

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/hydroxychloroquine-blood-levels-show-significant-trend-test-for-risk-of-retinopathy/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.